P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants

Clinical trial NCT06079775 · COMPLETED

Trial details

NCT number: NCT06079775
Sponsor: Qpex Biopharma, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bacterial Infections

Start date: 2024-01-30
Primary completion: 2025-01-05
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.